ALVITRIX: public contracts won without a rival in Nigeria: 2 uncontested awards; 100% of its awards; 0 without a competition; 2 single bid.
Assay record ASY-NG-0QYT0L319Q · Cite as: Assay Systems, “ALVITRIX: public contracts won without a rival in Nigeria”, https://assay-systems.com/register/ng/uncontested/s/alvitrix/
ALVITRIX won 2 of its 2 public contract awards in Nigeria without a rival from 2024-03-13 to 2024-03-13: 0 without a competition and 2 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest PROTOTYPE ENGINEERING DEVELOPMENT INSTITUTE , ILESHA with 2.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
PROTOTYPE ENGINEERING DEVELOPMENT INSTITUTE , ILESHA gave ALVITRIX 2 awards: 0 without a competition, 2 after a competition with a single bid. First 2024-03-13, latest 2024-03-13.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2024-03-13 | PROTOTYPE ENGINEERING DEVELOPMENT INSTITUTE , ILESHA ocds-gyl66f-228063001-000050 | Single bid open | Request for quotation |
| 2024-03-13 | PROTOTYPE ENGINEERING DEVELOPMENT INSTITUTE , ILESHA ocds-gyl66f-228063001-000016 | Single bid open | Request for quotation |
Every uncontested award in Nigeria · All countries
Source: contract awards published by the Bureau of Public Procurement of Nigeria (NOCOPO) and the Anambra and Osun State portals in the Open Contracting Data Standard (data.open-contracting.org), licensed under NOCOPO licence; awards from January 2016 to 30 September 2026, accessed 15 October 2026. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.